CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,603 | $3.26 | $5K | 559,812 |
| 2022-03-15 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | $2.80 | $6K | 557,812 |
| 2022-03-14 | Brooks Michael J President | Purchase | +1,250 | $2.79 | $3K | 16,741 |
| 2022-03-11 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | $3.18 | $6K | 550,812 |
| 2022-03-11 | Nijhawan Pardeep Chief Executive Officer | Purchase | +5,000 | $3.06 | $15K | 555,812 |
| 2022-03-10 | Brooks Michael J President | Purchase | +1,000 | $3.22 | $3K | 15,491 |
| 2022-03-09 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,500 | $3.05 | $5K | 548,812 |
| 2022-03-08 | Brooks Michael J President | Purchase | +1,250 | $2.90 | $4K | 14,491 |
| 2022-02-28 | Pay Paul William Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2022-02-28 | MacDonald Sean Arthur Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2022-02-28 | JOHNSON LORIN K Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2022-02-28 | OAKES FRANK R. Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2022-02-28 | Sistilli Carlo Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2022-02-28 | Brooks Michael J President | Grant or award · Stock Option (right to buy) | +43,500 | 43,500 | ||
| 2022-02-28 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Stock Option (right to buy) | +43,500 | 43,500 | ||
| 2022-02-28 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Stock Option (right to buy) | +49,000 | 49,000 | ||
| 2021-04-22 | JOHNSON LORIN K Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-04-22 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2021-04-22 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2021-04-22 | Brooks Michael J President | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 |
Page 7 of 15 · 284 trades